Skip to main content
Caplight Logo









Endo45

Endo45

Private
New PlymouthHealthcare & Life Scienceshttps://www.endo45.co.nz/

Last Round

Crowdfunding

Dec 1, 2025

Total Funding Raised

$2,700

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Endo45 operates in Healthcare & Life Sciences and is based in New Plymouth. Its latest recorded funding round was a Crowdfunding round in December 2025.

Endo45 is a health technology company that provides a mobile application for endometriosis symptom tracking, habit building, and evidence-based lifestyle management.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Endo45 Comparables

Compare Endo45 with similar companies based on industry and business-model similarity.

Endo45 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ENdi
83%
CHARLI Health
81%
Lyv Healthcare
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Endo45 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingDec 1, 2025
CrowdfundingNov 1, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Juliet Oliver

Co-Founder & CEO of Endo45

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 144% MoM, reaching 2.7K.

  • Nov 1, 2025

    Completed a crowdfunding round of funding.

Book a demo to see all signals

For institutional investors. Book with your work email.

Endo45 Filings

Explore SEC and related filing metadata, where available.

Endo45 filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Endo45's valuation, stock price, and market status.

Is Endo45 a public or private company?

Endo45 is a private company.

What is the current stock price of Endo45?

Endo45 is a private company, so its shares have no public market price. Caplight tracks Endo45's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Endo45 worth (valuation)?

Valuation information for Endo45 is not publicly available.

Can I buy Endo45 stock?

Endo45 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Endo45's last funding round?

Endo45's most recent funding round was Crowdfunding on December 1, 2025.

Who are the main investors in Endo45?

Investor information for Endo45 is not publicly disclosed.

Will Endo45 IPO soon?

No public IPO plans have been announced for Endo45.

How can I track Endo45 secondary market activity?

Caplight tracks bids, offers, and trades in Endo45's shares on secondary markets.

Firmographic Details

HeadquartersNew Plymouth
Employee Range4
Year Founded2020
Last FundingDec 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?